AMY STITES: Open Payments
NPI 1043676109 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,232 in 126 payments from 17 companies in 2025. Trend: 2023 $2,009 · 2024 $2,688 · 2025 $2,232
Food & beverage: $2,223Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $646 |
| Janssen Biotech, Inc. | 23 | $314 |
| Aimmune Therapeutics, Inc. | 20 | $283 |
| Madrigal Pharmaceuticals | 6 | $170 |
| Ipsen Biopharmaceuticals, Inc | 7 | $138 |
| GENZYME CORPORATION | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
| Ardelyx, Inc. | 5 | $84 |
| QOL Medical, LLC | 3 | $81 |
Products named: SKYRIZI, TREMFYA, ZENPEP, REZDIFFRA, RINVOQ, IQIRVO, DUPIXENT, ENTYVIO.
Industry payments across IL — which companies pay providers there.
